top of page

HPV Ato whom? Ne Time?


Cervical cancer occurs when cervical cells lose their normal structure and begin to grow and multiply uncontrollably. Over 90% of all cervical cancers have human papillomavirus (HPV) positivity. Therefore, the most important point in the prevention of cervical cancer is to be protected from HPV infection.

There are about 140 subtypes of HPV, of which about 40 are high-risk HPV types associated with female genital cancers (most commonly cervical cancer). The most common HPV types associated with cervical cancer are 16 and 18. Other subtypes of HPV (types 6 and 11) are associated with genital warts, but types that cause genital warts do not cause cancer.

Today, there are 3 types of vaccines against HPV in the world and 2 types in our country. One of the vaccines available in our country includes HPV types 16 and 18, while the other also includes HPV types 6 and 11 associated with genital warts. In addition to these vaccines, there are also vaccines that protect against 9 types of HPV that are in the world but have not yet entered the Turkish market.

The HPV vaccine, which is included in the routine screening program in many European countries, is recommended for children aged 11-12 before the first sexual intercourse. However, even if sexual intercourse has been experienced, both genders can be vaccinated between the ages of 9-26. It has even been found to be effective in women up to the age of 43. The vaccine is given as 2 doses before the age of 15 and 3 doses after the age of 15. Routine cervical cancer screening is continued for vaccinated patients.

bottom of page